Angion Biomedica is based in South San Francisco, CA. It has raised $900M in total funding. Latest round: IPO.
Angion Biomedica funding overview
Angion Biomedica is based in South San Francisco, CA. Angion Biomedica has raised $900M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in April 2020. The round record for Angion Biomedica runs through 2020; nothing later has been disclosed. Investors on record include Formic Ventures, SDL Ventures, U. S. National Science Foundation, U.S. Department of Health and Human Services. 4 distinct backers are named across the disclosed rounds.
Angion Biomedica at a glance
Total raised
$900M
Latest round
IPO
Latest round date
April 2020
Headquarters
South San Francisco, CA
Notable investors
Formic Ventures, SDL Ventures, U. S. National Science Foundation, U.S. Department of Health and Human Services
Frequently asked about Angion Biomedica funding
How much has Angion Biomedica raised?
Angion Biomedica has raised $900M in total disclosed funding across the rounds on record.
Who has invested in Angion Biomedica?
Formic Ventures, SDL Ventures, U. S. National Science Foundation, U.S. Department of Health and Human Services are named among the investors backing Angion Biomedica.
What was the latest Angion Biomedica funding round?
The most recent disclosed round is an IPO, announced in April 2020.
Where is Angion Biomedica based?
Angion Biomedica is based in South San Francisco, CA.
When did Angion Biomedica last raise?
The last disclosed Angion Biomedica round closed in April 2020 at IPO.
Every Angion Biomedica figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in South San Francisco at a similar stage.
